ME
Healthcare & Life Sciences
Metabolys
France
Metabolys is a Healthcare & Life Sciences startup based in France, since acquired, 1 tracked investor.
Acquiredacquired
acquired
Stage
1
Investors
About Metabolys
Metabolys is a startup based in France. Metabolys has been acquired. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Metabolys developed a proprietary, patent-protected peptide drug ('PATAS') that reverses insulin resistance to treat type 2 diabetes and related metabolic disorders by improving lipid biosynthesis in adipocytes, thereby restoring glycemic control and reducing cardiovascular and renal risks.
Explore Metabolys's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.